Controlled osteogenic differentiation of human mesenchymal stem cells (hMSCs) is initiated with the use of only single-walled carbon nanotube structures without any bio/chemical treatment. Oxygen plasma treatment of the carbon nanotubes is found to enhance the vitality of the hMSCs and promote osteogenic commitment.
No takes yet. Share an insight, caveat, or question.
Baik et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: